Article

Usefulness of Tissue Biomarkers versus Prostate-Spcific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy

2024-07-22

Abstract excerpt

Despite curative-intent local therapy, approximately 27% to 53% of prostate cancer (PCa) patients experience prostate-specific antigen (PSA) recurrence, known as biochemical recurrence (BCR). BCR significantly raises the risk of PCa-related morbidity and mortality, yet there is not consensus on optimal management. Prostate-specific membrane antigen-positron emission tomography (PSMA PET) has emerged as highly sens...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: da94d8e4-13f8-532a-97e4-8a8582bf9cad
DOI: 10.20944/preprints202407.1635.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Usefulness of Tissue Biomarkers versus Prostate-Spcific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical ProstatectomyDOI 10.20944/preprints202407.1635.v1Read

Multimodal Radiogenomic Machine Learning for Biochemical Recurrence Prediction Following Radical Prostatectomy Using PSMA-PET, mpMRI, and the Decipher Genomic ClassifierSemantic proximity Read

Assessment of biochemical recurrence of prostate cancer (Review)Semantic proximity Read

Biomarkers in Localized Prostate Cancer: Towards a Personalized MedicineSemantic proximity Read

Patterns of disease detection using 18F-DCFPyL PET/CT imaging in men with biochemical recurrence post prostatectomy being considered for salvage radiotherapy: a prospective trialSemantic proximity Read

Can We Predict Prostate Cancer Metastasis Based on Biomarkers? Where Are We Now?Semantic proximity Read

Follow-up Analysis of Intermediate-risk Prostate Cancer Patients Staged With Psma PET/CTSemantic proximity Read

Bivariate Diagnostic Paired Meta-Analysis at the Patient Level: Direct Validation of PSMA-PET against Conventional Imaging Across All T/N/M Staging Dimensions in Primary Intermediate- to High-Risk Prostate CancerSemantic proximity Read

Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI- Driven BiomarkersSemantic proximity Read

Deep learning from routine histology improves risk stratification for biochemical recurrence in prostate cancerSemantic proximity Read

Molecular diagnosis of prostate cancer: are we up to age?Semantic proximity Read

The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsSemantic proximity Read

Beyond PSMA: The essential complementary role of MRI in staging prostate cancer with Low-PSMA expression phenotypes.Semantic proximity Read